Search the webpage

Category: Angiogenesis

To test the anti-angiogenic potential of an NCE/compound in human umbilical vein endothelial cells (HUVEC) in vitro.



Human umbilical vein endothelial cells (HUVEC)


15-well µ-Slide Angiogenesis (Ibidi GmbH, Germany)

Angiogenic inducers and positive control

Inducers: incl. angiogenin and VEGF;
Positive control: sulforaphane.


ImageJ or Wimasis (Khoo et al., 2011)

Please contact us, if you would like to receive more information:


Human umbilical vein endothelial cells (HUVECs)

Assessment of anti-angiogenic properties of sulforaphane after an induction of angiogenesis using angiogenic and VEGF


  • Park HJ, Zhang Y, Georgescu SP, Johnson KL, Kong D, Galper JB. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis. Stem Cell Rev. 2006;2(2):93-102. Review. PubMed PMID: 17237547.
  • Cao Y, Gong Y, Liu L, Zhou Y, Fang X, Zhang C, Li Y, Li J. The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review. J Appl Toxicol. 2017 Dec;37(12):1359-1369. doi: 10.1002/jat.3470. Epub 2017 Apr 6. Review. PubMed PMID: 28383141.


  • Khoo CP, Micklem K, Watt SM. A comparison of methods for quantifying angiogenesis in the Matrigel assay in vitro. Tissue Eng Part C Methods. 2011 Sep;17(9):895-906. doi: 10.1089/ten.TEC.2011.0150. Epub 2011 Jun 8. PubMed PMID: 21517696;


Experimentica Ltd. opens a new R&D site in Lithuania

The investment totaling €1.6 million was supported, in part, by a competitive award “Smart FDI” (project no. 01.2.1-LVPA-T-848-01-005) under the ... Read More

Experimentica at BioJapan 2018

Experimentica Ltd. exhibits at BioJapan2018 partnering event in Pacifico Yokohama, Japan, on October 10 – October 12 ... Read More

Meet Experimentica Ltd. team at EVER 2018

Visit our booth to explore our state-of-the-art capabilities in preclinical research and our posters on diabetic retinopathy, glaucoma, dry and ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!